4JLK

Human dCK C4S-S74E mutant in complex with UDP and the F2.2.1 inhibitoR (2-[({2-[3-(2-FLUOROETHOXY)-4-METHOXYPHENYL]-5-METHYL-1,3-THIAZOL-4-YL}METHYL)SULFANYL]PYRIMIDINE-4,6-DIAMINE)

4JLK の概要

• エントリーDOI: 10.2210/pdb4jlk/pdb
• 関連するPDBエントリー: 4jlj 4JLM 4JLN
• 分子名称: Deoxycytidine kinase, URIDINE-5'-DIPHOSPHATE, 2-[({2-[3-(2-fluoroethoxy)-4-methoxyphenyl]-5-methyl-1,3-thiazol-4-yl}methyl)sulfanyl]pyrimidine-4,6-diamine, ... (4 entities in total)
• 機能のキーワード: phosphoryl transfer, phosphorylation, kinase, transferase-transferase inhibitor complex, transferase/transferase inhibitor
• 由来する生物種: Homo sapiens (human)
• 細胞内の位置: Nucleus: P27707
• タンパク質・核酸の鎖数: 2
• 化学式量合計: 67897.62

構造登録者

Nomme, J.,Lavie, A. (登録日: 2013-03-12, 公開日: 2013-09-18, 最終更新日: 2024-02-28)

• 主引用文献: Murphy, J.M.,Armijo, A.L.,Nomme, J.,Lee, C.H.,Smith, Q.A.,Li, Z.,Campbell, D.O.,Liao, H.I.,Nathanson, D.A.,Austin, W.R.,Lee, J.T.,Darvish, R.,Wei, L.,Wang, J.,Su, Y.,Damoiseaux, R.,Sadeghi, S.,Phelps, M.E.,Herschman, H.R.,Czernin, J.,Alexandrova, A.N.,Jung, M.E.,Lavie, A.,Radu, C.G.; Development of new deoxycytidine kinase inhibitors and noninvasive in vivo evaluation using positron emission tomography.; J.Med.Chem., 56:6696-6708, 2013; PubMed: 23947754; DOI: 10.1021/jm400457y

実験手法

X-RAY DIFFRACTION (1.89 Å)